AngioDynamics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
AngioDynamics, Inc. (ANGO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $40.40 million for the 12-month period ending 2016-05-31, per its 10-K filed 2017-08-04.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2017-08-04
- AngioDynamics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $40.40M, a 13366.67% increase from fiscal 2015.
- AngioDynamics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $300.00K, a 62.50% decline from fiscal 2014.
- AngioDynamics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $800.00K, a 60.00% increase from fiscal 2013.
- AngioDynamics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $500.00K, a 706.45% increase from fiscal 2012.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2016-05-31 | $40.40M 10-K · filed 2017-08-04 | |
| 2015-05-31 | $300.00K 10-K · filed 2015-08-10 | |
| 2014-05-31 | $800.00K 10-K · filed 2015-08-10 | |
| 2013-05-31 | $500.00K 10-K · filed 2015-01-12 | $484.00K 10-K · filed 2013-08-14 |
| 2012-05-31 | $62.00K 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |